Trivitron Healthcare sets up ultrasound manufacturing facility in India
Equipment

Trivitron Healthcare sets up ultrasound manufacturing facility in India

The ultrasound products manufactured in the new manufacturing facility will be sold under the brand name SonoRad, and are designed for large hospitals, healthcare institutions and individual radiology centres

  • By IPP Bureau | April 17, 2022

Trivitron Healthcare has set up its second ultrasound manufacturing facility in India at Patalganga Industrial Area, Mumbai. India is hugely dependent on the import of medical devices and this causes a huge impact on the country’s GDP and lack of proper healthcare facilities in the rural areas due to the heavy cost and comparative short shelf life of the imported devices, the company stated in a release.

Under the ‘Make in India’ initiative and ‘Atmanirbhar Bharat’, Trivitron Healthcare is focusing on making the best quality indigenous medical devices and diagnostic products to make healthcare equitable and accessible for all. The new manufacturing facility of Trivitron Healthcare will be manufacturing a wide range of advanced ultrasound devices and accessories, using the state of art manufacturing facilities and advanced technology as per the current market requirements to enhance medical practice in India and across the globe. The integrated cutting edge technology in the new ultrasound devices by Trivitron Healthcare makes them an ideal choice for those who want great quality and premium-level performance, the release further added.

The ultrasound products manufactured in the new manufacturing facility will be sold under the brand name SonoRad, and are designed for large hospitals, healthcare institutions and individual radiology centres.

‘Trivitron Healthcare strives for the vision of catalyzing higher quality of life with our best innovations and state-of-the-art manufacturing facilities in India. With our new indigenous manufacturing, we will contribute to cutting down on imports of ultrasound products. In the coming years, with focused business strategies, we will come up with many new indigenous product portfolios and make India the top destination for advanced healthcare and revolutionary medical technologies.’ shares Chandra Ganjoo, Group Chief Executive Officer, Trivitron Healthcare.

”With a potential for a strong domestic market and other endowing factors, India is set to emerge as an ideal destination for setting up manufacturing facilities. The set-up of indigenous manufacturing facilities will make an impact on the Indian healthcare system and preventive care by reducing high dependence on imports for addressing domestic demand.

The new SonoRad ultrasound series will provide important diagnostic information to our user, including maternal-fetal medicine dealing with the potential of high-risk pregnancies and for urology and cardiac imaging,’ shares Sudip Bagchi President, Trivitron Healthcare.

Upcoming E-conference

Other Related stories

Startup

Digitization